These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34235672)

  • 1. Determining Minimum Inhibitory Concentrations in Liquid Cultures or on Solid Medium.
    Wang Q; Boshoff HIM
    Methods Mol Biol; 2021; 2314():595-609. PubMed ID: 34235672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y; Permar S; Sun Z
    J Med Microbiol; 2002 Jan; 51(1):42-49. PubMed ID: 11800471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Heifets L; Sanchez T
    J Clin Microbiol; 2000 Apr; 38(4):1498-501. PubMed ID: 10747133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis.
    Lounis N; Vranckx L; Gevers T; Kaniga K; Andries K
    Med Mal Infect; 2016 Jun; 46(4):220-5. PubMed ID: 27210281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
    Gold B; Warrier T; Nathan C
    Methods Mol Biol; 2021; 2314():611-635. PubMed ID: 34235673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
    The Editors
    J Med Microbiol; 2002 Jan; 51(1):11-12. PubMed ID: 11800467
    [No Abstract]   [Full Text] [Related]  

  • 7. Microcolonies in fluoroquinolone agar proportion susceptibility testing of Mycobacterium tuberculosis: an indicator of drug resistance.
    Blackman A; May S; Devasia RA; Maruri F; Stratton C; Sterling TR
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2177-82. PubMed ID: 22322359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of agar-based medium with sheep sera for testing of drug susceptibility of Mycobacterium tuberculosis to Isoniazid, Rifampin, Ethambutol, and Streptomycin.
    Coban AY; Uzun M; Bozdogan B
    J Clin Microbiol; 2013 Dec; 51(12):4243-5. PubMed ID: 24131699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study for determination of Mycobacterium tuberculosis susceptibility to first- and second-line antituberculosis drugs by the Etest using 7H11, blood, and chocolate agar.
    Coban AY; Bilgin K; Uzun M; Akgunes A; Yusof A; Durupinar B
    J Clin Microbiol; 2008 Dec; 46(12):4095-8. PubMed ID: 18945843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Susceptibility Testing for Mycobacterium sps in High-Throughput Format.
    Pérez-Herrán E; Mendoza A
    Methods Mol Biol; 2021; 2314():637-648. PubMed ID: 34235674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
    Palomino JC; Martin A; Von Groll A; Portaels F
    J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring minimum inhibitory concentrations in mycobacteria.
    Sirgel FA; Wiid IJ; van Helden PD
    Methods Mol Biol; 2009; 465():173-86. PubMed ID: 20560078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of drug carryover effects in studies assessing antimycobacterial efficacy of TMC207.
    Lounis N; Gevers T; Van Den Berg J; Verhaeghe T; van Heeswijk R; Andries K
    J Clin Microbiol; 2008 Jul; 46(7):2212-5. PubMed ID: 18480227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10.
    Sturegård E; Ängeby KA; Werngren J; Juréen P; Kronvall G; Giske CG; Kahlmeter G; Schön T
    Clin Microbiol Infect; 2015 Feb; 21(2):148.e5-7. PubMed ID: 25640156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature.
    den Hertog AL; Menting S; Pfeltz R; Warns M; Siddiqi SH; Anthony RM
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4956-60. PubMed ID: 27270287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
    Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel agar base medium for drug susceptibility testing of
    Coban AY
    Future Microbiol; 2021 Sep; 16():949-953. PubMed ID: 34384261
    [No Abstract]   [Full Text] [Related]  

  • 18. The 7H11 Agar Medium Supplemented with Calf Bovine Serum for Susceptibility Testing of
    Amini S; Kardan-Yamchi J; Kazemian H; Nasiri MJ; Hamzehloo G; Hoffner S; Feizabadi MM
    Microb Drug Resist; 2021 Dec; 27(12):1652-1657. PubMed ID: 34077245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of three methods to determine the antimicrobial susceptibility of Mycobacterium tuberculosis.
    Muralidhar S; Srivastava L
    Indian J Med Res; 2004 Nov; 120(5):463-7. PubMed ID: 15591630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility testing of Mycobacterium tuberculosis isolates to primary antituberculous drugs on chocolate agar: a preliminary study].
    Coban AY; Bilgin K; Akgüneş A; Durupinar B
    Mikrobiyol Bul; 2008 Jul; 42(3):477-81. PubMed ID: 18822892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.